See also this year's filing and all EDGAR filings for this company.
PDF Report 0001311241_2019_Intermolecular_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001311241')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001311241, Intermolecular INC
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesCurrent | 6,342,000 |
| 1 | LiabilitiesNonCurrent | 0 |
| 2 | remainder_Liabilities | 2,667,000 |
| 3 | AssetsCurrent | 34,734,000 |
| 4 | AssetsNonCurrent | 514,000 |
| 5 | IntangibleAssets | 2,075,000 |
| 6 | PropertyPlantAndEquipmentNet | 3,432,000 |
| 7 | remainder_Assets | 2,638,000 |
| 8 | ResearchAndDevelopmentExpense | 17,228,000 |
| 9 | SellingGeneralAndAdministrativeExpense | 10,772,000 |
| 10 | AmortizationOfIntangibleAssets | 0 |
| 11 | remainder_Expenses | 10,009,000 |
| 12 | remainder_Revenues | 33,660,000 |
| 13 | remainder_NetIncome | 938,000 |
| 14 | remainder_ComprehensiveNetIncome | 9,000 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 9,009,000 |
| 1 | Assets | 43,393,000 |
| 2 | Expenses | 38,009,000 |
| 3 | Revenues | 33,660,000 |
| 4 | StockholdersEquity | 34,384,000 |
| 5 | NetIncome | -3,411,000 |
| 6 | ComprehensiveNetIncome | -3,402,000 |
| 7 | BaseVar | 165,260,640 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.57 |
| 9 | EconomicCapitalRatio | 2.60 |
Edgar->Model Mapping
Feature Distribution
Change over Time
